个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis

  作者 GOMEZGALENO JORGE E; DANG QUN; NGUYEN THANH H; BOYER SERGE H; GROTE MATTHEW P; SUN ZHILI; CHEN MINGWEI; CRAIGO WILLIAM A; VAN POELJE PAUL D; MACKENNA DEIDRE A; CABLE EDWARD E; ROLZIN PAUL A; FINN PATRICIA D; CHI BERT; LINEMEYER DAVID L; HECKER SCOTT J; ERION MARK D  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2010年1-9;  页码  478-482  
  关联知识点  
 

[摘要]AMP-activated protein kinase (AMPK) is a heterotrimeric kinase that regulates cellular. energy metabolism by affecting energy-consuming pathways such as de novo. lipid biosynthesis and glucose production as well as energy-producing pathways such as lipid oxidation and glucose uptake. Accordingly, compounds that activate AMPK represent potential drug candidates for the treatment of hyperlipidemia and type 2 diabetes. Screening of a proprietary library of AMP mimetics identified the phosphonic acid 2 that bears little structural resemblance to AMP but is capable of activating AMPK with high potency (EC50 = 6 nM vs AMP EC50 = 6 mu M) and specificity. Phosphonate prodrugs of 2 inhibited de novo lipogenesis In cellular and animal models of hyperlipidemia.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内